Cure Alzheimer’s Fund Honors Breakthrough Research with Jeffrey L. Morby Prize

The Cure Alzheimer’s Fund has recognized the groundbreaking work of Andrew S. Yoo, Ph.D., and Zhao Sun, Ph.D., from Washington University School of Medicine in St. Louis, with the second annual Jeffrey L. Morby Prize. Their research, published in Science, introduces a novel method to study aged neurons in the lab, bypassing the need for brain biopsies and offering new avenues for understanding late-onset Alzheimer’s disease (AD).

The Morby Prize, named after the late co-founder of Cure Alzheimer’s Fund, Jeffrey L. Morby, celebrates research that significantly advances the understanding of Alzheimer’s disease. This year’s award includes a $200,000 grant to support further Alzheimer’s-related research in Dr. Yoo’s lab. The study’s approach to transforming skin cells into neurons that mimic the aging process allows scientists to observe disease features like amyloid beta plaque buildup, providing critical insights into AD’s development and potential treatments.

Meg Smith, CEO of Cure Alzheimer’s Fund, highlighted the importance of the award in continuing Jeff Morby’s legacy of supporting innovative research. The selection of Drs. Yoo and Sun’s work by their peers underscores its potential impact on the Alzheimer’s community. Dr. Yoo expressed enthusiasm for the prize’s support in exploring how aging affects different neuronal subtypes, offering hope for targeted treatments.

This research not only advances the scientific community’s understanding of Alzheimer’s disease but also opens new pathways for developing diagnostic tools and therapies. The implications of this study are vast, promising to accelerate the fight against a disease that affects millions worldwide, with the potential to significantly improve patient outcomes in the future.